ProfileGDS4718 / 221730_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 37% 48% 86% 26% 42% 64% 82% 36% 52% 38% 40% 44% 70% 83% 72% 61% 52% 83% 73% 86% 56% 57% 48% 48% 40% 81% 37% 70% 32% 30% 33% 86% 46% 37% 90% 89% 35% 72% 39% 93% 44% 57% 98% 82% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8445437
GSM549102patient 115, normal, homogenized [OPG study]5.4466448
GSM549104patient 119, normal, homogenized [OPG study]8.6985586
GSM549108patient 138, normal, homogenized [OPG study]4.4156126
GSM549119patient 077, normal, homogenized [OPG study]5.1052242
GSM549133patient 032, cancer, homogenized [OPG study]6.3760864
GSM549139patient 042, cancer, homogenized [OPG study]8.0937382
GSM549099patient 107, normal, homogenized [OPG study]4.845336
GSM549109patient 139, normal, homogenized [OPG study]5.6409452
GSM549110patient 046, normal, homogenized [OPG study]4.9052638
GSM549114patient 063, normal, homogenized [OPG study]4.9331740
GSM549122patient 082, normal, homogenized [OPG study]5.1862244
GSM549134patient 033, cancer, homogenized [OPG study]6.9108470
GSM549136patient 036, cancer, homogenized [OPG study]8.2505983
GSM549140patient 044, cancer, homogenized [OPG study]7.1139872
GSM549111patient 047, normal, homogenized [OPG study]6.2053961
GSM549113patient 057, normal, homogenized [OPG study]5.5596752
GSM549132patient 031, cancer, homogenized [OPG study]8.1477883
GSM549137patient 038, cancer, homogenized [OPG study]7.1658773
GSM549142patient 047, cancer, homogenized [OPG study]8.2599686
GSM549100patient 110, normal, homogenized [OPG study]5.8577256
GSM549107patient 135, normal, homogenized [OPG study]5.8874557
GSM549115patient 068, normal, homogenized [OPG study]5.3700748
GSM549116patient 072, normal, homogenized [OPG study]5.3977848
GSM549120patient 078, normal, homogenized [OPG study]4.973440
GSM549131patient 030, cancer, homogenized [OPG study]8.0993581
GSM549118patient 074, normal, homogenized [OPG study]4.834237
GSM549129patient 027, cancer, homogenized [OPG study]6.9663270
GSM549123patient 088, normal, homogenized [OPG study]4.6162532
GSM549124patient 006, cancer, homogenized [OPG study]4.5874930
GSM549126patient 015, cancer, homogenized [OPG study]4.6732833
GSM549128patient 025, cancer, homogenized [OPG study]8.5965186
GSM549103patient 117, normal, homogenized [OPG study]5.3454246
GSM549117patient 073, normal, homogenized [OPG study]4.798937
GSM549138patient 041, cancer, homogenized [OPG study]9.2492490
GSM549141patient 045, cancer, homogenized [OPG study]9.132589
GSM549130patient 028, cancer, homogenized [OPG study]4.7779235
GSM549101patient 111, normal, homogenized [OPG study]7.0459272
GSM549105patient 128, normal, homogenized [OPG study]4.9471939
GSM549106patient 134, normal, homogenized [OPG study]9.8689293
GSM549112patient 048, normal, homogenized [OPG study]5.1898444
GSM549125patient 011, cancer, homogenized [OPG study]5.9121357
GSM549127patient 024, cancer, homogenized [OPG study]11.227898
GSM549135patient 035, cancer, homogenized [OPG study]8.2553782